BioTroy empowers first-in-class IO therapeutics by ensuring high diversity, affinity and developability in the antibody discovery process.
The creative design of antigen preparation, immunization and screening strategies are driven by our insights into the biological functions of the target and relevant physiopathological processes. A highly motivated team led by experts in both oncoimmunology and antibody engineering ensure the unlimited approximity to "best-in-class" molecules.